EICHORCondition: Allergic Conjunctivitis · Sponsor: Alcon Research
The purpose of this study is to assess the ocular comfort and safety of olopatadine hydrochloride opthalmic solution. 0.7%.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Able to be dosed in both eyes, to follow instructions, and willing and able to attend required study visits. * Negative urine pregnancy test if female of childbearing potential and use adequate birth control throughout the study period. * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * History or clinical evidence of ocular herpes simplex or ocular herpes zoster infectious disease. * History of any clinically significant external ocular disease within 30 days of the start of the study. * Presence of active blepharitis, active meibomian gland dysfunction, active rosacea affecting the ocular surface/lid margin, active or chronic follicular conjunctivitis, preauricular adenopathy, or any other ocular or periocular abnormality that may affect the study outcomes. * Other protocol-defined exclusion criteria may apply.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Locations not yet listed on the registry record. |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01326858